Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Acid Reducer (Ranitidine) 75 mg Tablet; Maximum Strength Acid reducer (Ranitidine) 150 mg Tablet without prescription

Canada Type I Ongoing · initiated 2021-12-03

Contamination. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health conc…

CanPrev Omega Twist & Cyto Matrix Omega Boost

Canada Type III Ongoing · initiated 2021-12-01

Labelling. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns…

Nerfasin 20

Canada Type I Ongoing · initiated 2021-11-30

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Dotarem Injection

Canada Type I Ongoing · initiated 2021-11-22

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Odor-Eaters

Canada Type II Ongoing · initiated 2021-11-19

Contamination. Stop using the affected products. Consult a health care professional if you have used any of these products and have health concerns.Visit the co…

MAR-Paliperidone Extended Release tablets.

Canada Type II Ongoing · initiated 2021-11-16

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Verkazia

Canada Type II Ongoing · initiated 2021-11-15

Product safety. If you see particulate matter (e.g. crystal-like particles) in the vials or if your eye symptoms worsen, stop using the product and consult your…

MAR-Cetirizine

Canada Type II Ongoing · initiated 2021-11-09

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

JAMP-Cetirizine

Canada Type II Ongoing · initiated 2021-11-09

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

TUMS Extra Strength

Canada Type II Ongoing · initiated 2021-11-03

Product safety. Stop using the recalled product. Talk to your healthcare provider if you have taken a recalled product and have health concerns.Contact GSK Cons…

Sandoz Orphenadrine

Canada Type II Ongoing · initiated 2021-10-27

Contamination

Mint-Losartan

Canada Type I Ongoing · initiated 2021-10-25

Contamination

Vitamin K1 INJ 1mg/0.5mL USP

Canada Type II Ongoing · initiated 2021-10-22

Product quality

Baciject (Bacitracin for Injection USP) 50,000 units per vial (2021-10-20)

Canada Type II Ongoing · initiated 2021-10-20

Product safety

Sivem Pharmaceuticals Losartan HCT product recall (2021-10-13)

Canada Type I Ongoing · initiated 2021-10-13

Product safety

Pharmascience PMS-Losartan product recall (2021-10-13)

Canada Type I Ongoing · initiated 2021-10-13

Product safety

Ombrelle product recall (2021-10-13)

Canada Type II Ongoing · initiated 2021-10-13

Product safety

Auro Pharma Losartan product recall (2021-10-12)

Canada Type I Ongoing · initiated 2021-10-12

Product safety

Alcohol Antiseptic 80% (v/v) Topical Solution Hand Sanitizer (2021-10-08)

Canada Unclassified Ongoing · initiated 2021-10-08

COVID

Riva-Risperidone (2021-10-07)

Canada Type I Ongoing · initiated 2021-10-07

Product safety

Novo-Gesic Forte (2021-10-06)

Canada Type I Ongoing · initiated 2021-10-06

Product safety

Advil Cold & Sinus Convenience Pack (2021-10-02)

Canada Type II Ongoing · initiated 2021-10-02

Product safety

Auro Pharma Losartan product recall (2021-10-01)

Canada Type I Ongoing · initiated 2021-10-01

Product safety

Bayer-Tinactin product recall (2021-10-01)

Canada Type II Ongoing · initiated 2021-10-01

Product safety

Vita Health Ibuprofen product recall (2021-10-01)

Canada Type III Ongoing · initiated 2021-10-01

Product safety